ASSET | DATE | % RETURN |
---|---|---|
Plug Power (PLUG) | 10/23/2013 - 1/30/2014 | 420% |
Camtek (CAMT) | 10/23/2013 - 1/30/2014 | 192.7% |
Corcept Therapeutics (CORT) | 10/23/2013 - 1/30/2014 | 115.61% |
Mr Cooper (COOP) | 10/23/2013 - 1/30/2014 | 113.68% |
Novavax (NVAX) | 10/23/2013 - 1/30/2014 | 110.88% |
TKO (TKO) | 10/23/2013 - 1/30/2014 | 103.77% |
Harrow Health (HROW) | 10/23/2013 - 1/30/2014 | 97.12% |
Arrowhead Pharmaceuticals (ARWR) | 10/23/2013 - 1/30/2014 | 92.7% |
AerCap (AER) | 10/23/2013 - 1/30/2014 | 86.31% |
Frontline (FRO) | 10/23/2013 - 1/30/2014 | 83.05% |
CMBTECH (CMBT) | 10/23/2013 - 1/30/2014 | 77.84% |
ANI Pharmaceuticals (ANIP) | 10/23/2013 - 1/30/2014 | 74.98% |
Danaos (DAC) | 10/23/2013 - 1/30/2014 | 74.62% |
Incyte (INCY) | 10/23/2013 - 1/30/2014 | 73.54% |
Jazz Pharmaceuticals (JAZZ) | 10/23/2013 - 1/30/2014 | 72.62% |
Illumina (ILMN) | 10/23/2013 - 1/30/2014 | 69.84% |
MakeMyTrip (MMYT) | 10/23/2013 - 1/30/2014 | 69.5% |
Perdoceo Education (PRDO) | 10/23/2013 - 1/30/2014 | 69.07% |
Logitech International (LOGI) | 10/23/2013 - 1/30/2014 | 67.65% |
AtriCure (ATRC) | 10/23/2013 - 1/30/2014 | 67.17% |
Neurocrine Biosciences (NBIX) | 10/23/2013 - 1/30/2014 | 65.41% |
BioCryst Pharmaceuticals (BCRX) | 10/23/2013 - 1/30/2014 | 63.56% |
Canadian Solar (CSIQ) | 10/23/2013 - 1/30/2014 | 62.94% |
DHT (DHT) | 10/23/2013 - 1/30/2014 | 62.33% |
Supernus Pharmaceuticals (SUPN) | 10/23/2013 - 1/30/2014 | 59.19% |